Welcome to LookChem.com Sign In|Join Free
  • or
DL-Homocysteine is an amino acid that plays a crucial role in various biological processes. It is synthesized from methionine and is involved in the transsulfuration pathway, which is essential for the synthesis of cysteine and glutathione. DL-Homocysteine is also a precursor for the synthesis of other important molecules, such as taurine and inositol. Elevated levels of homocysteine in the blood, known as hyperhomocysteinemia, have been associated with an increased risk of cardiovascular diseases, neurological disorders, and other health issues.
Used in Pharmaceutical Research:
DL-Homocysteine is used as a research compound for studying the effects of hyperhomocysteinemia on various physiological and pathological processes. It is particularly useful in investigating the role of homocysteine in the development of atherosclerosis and other cardiovascular diseases.
Used in Animal Models:
DL-Homocysteine is used as a treatment to induce hyperhomocysteinemia in animal models, such as Sprague-Dawley rats. This allows researchers to study the effects of elevated homocysteine levels on various physiological and pathological processes, as well as to test potential therapeutic interventions.
Used in Atherosclerosis Research:
DL-Homocysteine is used as a research tool to study the effects of hyperhomocysteinemia on atherosclerosis in apolipoprotein E-deficient mice. This helps researchers to better understand the mechanisms by which elevated homocysteine levels contribute to the development and progression of atherosclerosis, and to identify potential targets for therapeutic intervention.

454-29-5

Post Buying Request

454-29-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

454-29-5 Usage

Biochem/physiol Actions

Homocysteine is a sulfhydryl-containing amino acid, synthesized from methionine. It is a non-essential, non-proteinogenic amino acid. It is an important determinant of the methylation cycle and is present in the plasma in four forms. An abnormally high level of homocysteine leads to hyperhomocysteinemia and also promotes atherosclerosis.

Purification Methods

Purify it as for the L-isomer. [Allen & Steinmann J Am Chem Soc 74 3932 1952, and references for the L-isomer above, Beilstein 4 IV 3189.]

Check Digit Verification of cas no

The CAS Registry Mumber 454-29-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,5 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 454-29:
(5*4)+(4*5)+(3*4)+(2*2)+(1*9)=65
65 % 10 = 5
So 454-29-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m1/s1

454-29-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0159)  DL-Homocysteine  >90.0%(T)

  • 454-29-5

  • 1g

  • 415.00CNY

  • Detail
  • TCI America

  • (H0159)  DL-Homocysteine  >90.0%(T)

  • 454-29-5

  • 5g

  • 1,330.00CNY

  • Detail
  • Sigma

  • (H4628)  DL-Homocysteine  ≥95% (titration)

  • 454-29-5

  • H4628-10MG

  • 190.71CNY

  • Detail
  • Sigma

  • (H4628)  DL-Homocysteine  ≥95% (titration)

  • 454-29-5

  • H4628-1G

  • 258.57CNY

  • Detail
  • Sigma

  • (H4628)  DL-Homocysteine  ≥95% (titration)

  • 454-29-5

  • H4628-5G

  • 1,090.44CNY

  • Detail
  • Sigma

  • (H4628)  DL-Homocysteine  ≥95% (titration)

  • 454-29-5

  • H4628-25G

  • 4,797.00CNY

  • Detail
  • Sigma-Aldrich

  • (44925)  DL-Homocysteine  analytical standard

  • 454-29-5

  • 44925-25MG

  • 521.82CNY

  • Detail

454-29-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name DL-Homocysteine

1.2 Other means of identification

Product number -
Other names 1-carboxy-3-mercaptopropylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:454-29-5 SDS

454-29-5Relevant academic research and scientific papers

New thiazane and thiazolidine PNA monomers: Synthesis, incorporation into PNAs and hybridization studies

Bregant, Sarah,Burlina, Fabienne,Chassaing, Gerard

, p. 1047 - 1050 (2002)

New constrained PNA monomers containing a substituted thiazolidine or a thiazane ring were synthesized and incorporated in the center of a 9-mer homothymine PNA. The PNA/DNA hybrids stability was studied by UV-melting experiments which showed that the presence of the modified unit destabilizes the PNA/DNA triplexes.

A quantitative method for the assessment of homocysteine thiolactonase enzyme activity

Obeid, Nassr J.,Hadwan, Mahmoud Hussein

, (2021/09/14)

This assay elucidates an accurate, simple, and precise protocol to quantify the activity of homocysteine thiolactonase (HTase). To establish HTase activity, the enzyme samples were incubated with a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, which contained suitable concentrations of the homocysteine thiolactone as a substrate. To stop the enzyme's reaction, the CUPRAC reagent (Cu(Nc)22+) was added after a suitable incubation time. The reduction of Cu(II)-neocuproine complex (Cu(Nc)22+) to highly coloured Cu(I)-neocuproine complex (Cu(Nc)2+) by the produced homocysteine was quantified spectrophotometrically at 450 nm (CUPRAC method). The increase in the absorbance of the coloured Cu(I)-neocuproine complex (Cu(Nc)2+) was correlated directly to the activity of HTase. ANOVA analysis was utilised to validate the new method against homocysteine thiolactonase activity using the H+ ions liberating method in matched samples. In conclusion, according to the obtained correlation coefficient (0.9995) from the comparison of the current method with the reference method, the current method is effective in assay HTase activity with high reliability.

An Organodiselenide with Dual Mimic Function of Sulfhydryl Oxidases and Glutathione Peroxidases: Aerial Oxidation of Organothiols to Organodisulfides

Rathore, Vandana,Upadhyay, Aditya,Kumar, Sangit

supporting information, p. 6274 - 6278 (2018/10/05)

A novel organodiselenide, which mimics sulfhydryl oxidases and glutathione peroxidase (GPx) enzymes for oxidation of thiols by oxygen and hydrogen peroxide, respectively, into disulfides has been presented. The developed catalyst oxidizes an array of organothiols into respective disulfides in practical yields by using aerial O2 to avoid any reagents/additives, base, and light source. The synthesized diselenide also catalyzes the reduction of hydrogen peroxide into water by following the GPx enzymatic catalytic cycle with a reduction rate of 49.65 ± 3.7 μM·min-1.

Novel synthetic method of DL-homocysteinethiolactone hydrochloride

-

Paragraph 0018; 0019; 0020; 0021; 0022; 0023; 0024-0034, (2018/01/03)

The invention discloses a novel synthetic method of DL-homocysteinethiolactone hydrochloride. According to the novel synthetic method, DL-methionine and metallic sodium are subjected to reduction reaction, an obtained reduction product is subjected to desalting, and is subjected to condensation de-watering in the presence of dilute hydrochloric acid so as to obtain the DL-homocysteinethiolactone hydrochloride. DL-homocysteine is obtained via one-step synthesis from methionine, and DL-homocysteinethiolactone hydrochloride is obtained via condensation of DL-homocysteine under acid conditions, so that a re-reduction process of conversion of DL-methionine into DL-homocysteine in the prior art is avoided, reaction steps are reduced, harsh high temperature reaction conditions are avoided, release of hypertoxic gas and production of a large amount of high-salt waste water are reduced, three waste discharge is reduced, and a large amount of energy consumption is reduced; and in addition, the medium used in the novel synthetic method can be recycled, and cost is reduced. The novel synthetic method is capable of satisfying green and environment-friendly technology requirements; operation is simple; preparation is convenient; cost is low; and the novel synthetic method is suitable for industrialized large scale production.

Reaction of hydrogen sulfide with disulfide and Sulfenic acid to form the strongly Nucleophilic Persulfide

Cuevasanta, Ernesto,Lange, Mike,Bonanata, Jenner,Coiti?o, E. Laura,Ferrer-Sueta, Gerardo,Filipovic, Milos R.,Alvarez, Beatriz

, p. 26866 - 26880 (2015/11/17)

Background: Hydrogen sulfide (H2S) modulates physiological processes in mammals. Results: The reactivity of H2S toward disulfides (RSSR) and albumin sulfenic acid (RSOH) to form persulfides (RSSH) was assessed. Conclusion: H2S is less reactive than thiols. Persulfides have enhanced nucleophilicity. Significance: This kinetic study helps rationalize the contribution of the reactions with oxidized thiol derivatives toH2S biology.

Immunomodulatory peptides

-

, (2014/12/12)

The invention relates to peptides derivatized with a hydrophilic polymer which, in some embodiments, bind to human FcRn and inhibit binding of the Fc portion of an IgG to an FcRn, thereby modulating serum IgG levels. The disclosed compositions and methods may be used in some embodiments, for example, in treating autoimmune diseases and inflammatory disorders. The invention also relates, in further embodiments, to methods of using and methods of making the peptides of the invention.

A green and expedient synthesis of enantiopure diketopiperazines via enzymatic resolution of unnatural amino acids

Pereira, Pedro C.,Arends, Isabel W.C.E.,Sheldon, Roger A.

supporting information, p. 4991 - 4993 (2015/01/09)

Dipeptides comprising a d-phenylglycyl moiety coupled to the l-enantiomer of 2-amino butyric acid, norvaline, norleucine, and homocysteine were successfully synthesized from d-phenylglycine amide and the racemate of the corresponding unnatural amino acid.

METHOD FOR PREPARING AN AMINO ACID FROM 2 AMINOBUTYROLACTONE

-

Paragraph 0031; 0032; 0033; 0034; 0035; 0036, (2013/07/25)

The invention relates to a method for preparing an amino acid, or its salts, from 2-aminobutyrolactone (2ABL), said amino acid fitting the formula I, XCH2CH2CHNH2COOH, wherein X is such that X? represents a nucleophilic ion, according to which N-carboxylation of 2-aminobutyrolactone (2ABL) is achieved with carbon dioxide, and the thereby obtained 2ABL carbamate is reactive with an XH reagent or its salts.

Protein thiocarboxylate-dependent methionine biosynthesis in Wolinella succinogenes

Krishnamoorthy, Kalyanaraman,Begley, Tadhg P.

experimental part, p. 379 - 386 (2011/03/16)

Thiocarboxylated proteins are important intermediates in a variety of biochemical sulfide transfer reactions. Here we identify a protein thiocarboxylate-dependent methionine biosynthetic pathway in Wolinella succinogenes. In this pathway, the carboxy terminal alanine of a novel sulfur transfer protein, HcyS-Ala, is removed in a reaction catalyzed by a metalloprotease, HcyD. HcyF, an ATP-utilizing enzyme, catalyzes the adenylation of HcyS. HcyS acyl-adenylate then undergoes nucleophilic substitution by bisulfide produced by Sir to give the HcyS thiocarboxylate. This adds to O-acetylhomoserine to give HcyS-homocysteine in a PLP-dependent reaction catalyzed by MetY. HcyD-mediated hydrolysis liberates homocysteine. A final methylation completes the biosynthesis. The biosynthetic gene cluster also encodes the enzymes involved in the conversion of sulfate to sulfide suggesting that sulfate is the sulfur source for protein thiocarboxylate formation in this system.

Inhibitors of autoinducer transporters

-

, (2008/06/13)

The present invention relates to the discovery of the lsr operon, the genes therein, and the polypeptides encoded by these genes. The present invention also includes strains with altered expression levels of the polypeptides encoded by the genes and the lsr operon relative to wild type cells. In some embodiments, the strains express a transporter that transports an autoinducer into the cell at a level higher than that of wild type cells. The present invention also includes methods for identifying compounds that modulate the transport of the autoinducer into cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 454-29-5